---
layout: post
title: "步长制药02月14日获沪股通增持30.6万股"
date: 2022-02-15 07:46:04 +0800
categories: dongfangcaifuChoiceshuju
tags: 东方财富Choice数据新闻
---
<p style="display:none; height:1px; overflow:hidden;"></p><p style="text-align: center;"><a href="http://quote.eastmoney.com/unify/r/1.603858" data-code="603858|1|1" data-code2="603858|1|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.603858&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f" border="0" alt="K图 603858_0" data-code="K 603858|1|1" data-code2="K 603858|1|2|" style="border: #d1d1d1 1px solid;"></a></p><p>02月14日，步长制药获沪股通增持30.6万股，最新持股量为2518.84万股，占公司A股总股本的2.21%。</p><p><strong>近五日持股量数据</strong></p><img class="autoimg" src="https://dfscdn.dfcfw.com/download/D2FB32BA44C5C9EFAEFA6DD5132B9C6AF9_w670h200.jpg" alt=""><p><strong>持股量及股价变动图</strong></p><img id="image9" class="autoimg" src="https://dfscdn.dfcfw.com/download/D2409B980CE94CD2A13CC1284A4E85C928_w800h400.jpg" alt=""><span class="autosrc">注：文中持股数量经过前复权处理，可能存在与港交所披露不一致的情形。</span><p style="margin: 10px 0; color: #999">免责声明：本文基于大数据生产，仅供参考，不构成任何投资建议，据此操作风险自担。</p><style>.autoimg {display: block;border: 0;max-width: 100%;margin: 0 auto;} .tbl {border-collapse: collapse;border-spacing: 0;text-align: center;width: 100% !important;} .tbl tr th, .tbl tr td {border: 1px solid #d8e6ff;padding: 5px;text-align: center;} .tbl tr th {color: #fff;background-color: #1c65b0;vertical-align: middle;} .tbl tr td {color: #000;background-color: #fff;} .imgtitle {text-indent: 0;text-align: center;color: #2395F1;} .autosrc {color: #999;display: block;text-align: center;margin-bottom: 5px;}</style>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202202152276303375>

[返回东方财富Choice数据新闻](//finews.withounder.com/category/dongfangcaifuChoiceshuju.html)｜[返回首页](//finews.withounder.com/)